Hyprevention Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $16.1M

  • Investors
  • 4

Hyprevention General Information

Description

Operator of a medical company intended to develop implantable medical devices to address unmet clinical needs. The company's product is an implantable medical device indicated for internal fixation of the proximal femur of patients at risk of osteoporotic fracture and for impeding pathological fracture, enabling clinicians to treat osteoporotic, cancer and improving patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Corporate Office
  • Xavier Arnozan Hospital
  • Avenue du Haut-Lévêque
  • 33604 Pessac
  • France
+33 05 00 00 00 00

Hyprevention Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hyprevention Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-May-2024 $16.1M 0000 Completed Generating Revenue
5. Later Stage VC 02-Mar-2023 00.000 00.00 0000 Completed Generating Revenue
4. Later Stage VC 07-Apr-2022 00.000 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 28-Sep-2020 00.000 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 18-Nov-2017 $101K $908K 00.000 Completed Generating Revenue
1. Seed Round 15-Dec-2015 $807K $807K Completed Generating Revenue
To view Hyprevention’s complete valuation and funding history, request access »

Hyprevention Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 000.0 000.0 00 000.0 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 28,838 $1.070679 $9.1 $9.1 1x $9.1 3.35%
Ordinary 59,700 $1.070679 $1.55 $1.55 1x $1.55 6.93%
To view Hyprevention’s complete cap table history, request access »

Hyprevention Patents

Hyprevention Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015342167-B2 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014 00000000000 0
AU-2015342167-A1 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014 0000000000
EP-3017780-A1 Implant for stabilizing fractured or non-fractured bones Inactive 04-Nov-2014 0000000000 00
EP-3215037-B1 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014 0000000000 0
EP-3215037-A1 Implant for stabilizing fractured or non-fractured bones Active 04-Nov-2014 A61B17/725 0
To view Hyprevention’s complete patent history, request access »

Hyprevention Executive Team (1)

Name Title Board Seat Contact Info
Cecile Vienney Founder, Chief Executive Officer and President
To view Hyprevention’s complete executive team members history, request access »

Hyprevention Board Members (1)

Name Representing Role Since
Kathryn Larson Hyprevention Board Member 000 0000
To view Hyprevention’s complete board members history, request access »

Hyprevention Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hyprevention Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Caisse d'Epargne Corporation Minority 000 0000 000000 0
Yellowstone Holding Venture Capital Minority 000 0000 000000 0
Be Angels Angel Group Minority 000 0000 000000 0
Expanso Capital Corporate Venture Capital Minority 000 0000 000000 0
To view Hyprevention’s complete investors history, request access »

Hyprevention FAQs

  • When was Hyprevention founded?

    Hyprevention was founded in 2010.

  • Who is the founder of Hyprevention?

    Cecile Vienney is the founder of Hyprevention.

  • Who is the CEO of Hyprevention?

    Cecile Vienney is the CEO of Hyprevention.

  • Where is Hyprevention headquartered?

    Hyprevention is headquartered in Pessac, France.

  • What is the size of Hyprevention?

    Hyprevention has 10 total employees.

  • What industry is Hyprevention in?

    Hyprevention’s primary industry is Therapeutic Devices.

  • Is Hyprevention a private or public company?

    Hyprevention is a Private company.

  • What is Hyprevention’s current revenue?

    The current revenue for Hyprevention is 000000.

  • How much funding has Hyprevention raised over time?

    Hyprevention has raised $26M.

  • Who are Hyprevention’s investors?

    Caisse d'Epargne, Yellowstone Holding, Be Angels, and Expanso Capital have invested in Hyprevention.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »